Filing Details

Accession Number:
0000875045-21-000060
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-28 08:11:20
Reporting Period:
2021-12-23
Accepted Time:
2021-12-28 08:11:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001233 Sangamo Therapeutics Inc SGMO Biological Products, (No Disgnostic Substances) (2836) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
875045 Biogen Inc. 225 Binney St.
Cambridge MA 02142
No No Yes No
1810387 Biogen Ma Inc. 225 Binney St.
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-23 81,187 $8.55 24,155,830 No 4 S Indirect By Biogen MA Inc.
Common Stock Disposition 2021-12-27 600 $8.56 24,155,230 No 4 S Indirect By Biogen MA Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Biogen MA Inc.
No 4 S Indirect By Biogen MA Inc.
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.50 to $8.65, inclusive. The reporting person undertakes to provide to Sangamo Therapeutics, Inc., any security holder of Sangamo Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. Shares are owned indirectly by Biogen Inc. and directly by its wholly-owned subsidiary Biogen MA Inc.